1 / 17

Vitamin D Supplements: Evidence and Effects in Respiratory Conditions

This review delves into recent trials and analyses on the effectiveness of Vitamin D supplementation for respiratory tract infections, asthma, and other related conditions. From bolus dosing to daily intake, the evidence points to varying outcomes, highlighting the importance of Vitamin D levels in determining efficacy.

hannahj
Download Presentation

Vitamin D Supplements: Evidence and Effects in Respiratory Conditions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vitamin D: current state of the evidence John Hickner, MD, MS Editor-in-Chief, Journal of Family Practice

  2. Objective Review recent randomized trials and meta-analyses describing the conditions for which Vitamin D supplementation is effective, ineffective or of unknown effectiveness.

  3. Respiratory Tract Infections 1. Bolus dosing of Vitamin D does not prevent ARTI or asthma exacerbation in vitamin D–deficient patients • RCT: 590 patients with asthma, all using inhaled steroids • 120,000 IU Vit D q2 month or not • 82% had low vitD levels less than 30 ng/ml • No effect on exacerbations 2. Vitamin D does not reduce URIs in children age one to five • RCT: 703 children given either 2,000 IU daily or 400 IU daily • Mean of 1.05 ARI vs 1.03 in low dose group • No difference in any of the other outcomes • Flaw: both groups probably had adequate VitD levels

  4. Respiratory Tract Infections 3. No effect of Vitamin D3 supplementation on respiratory tract infections in healthy individuals • 2016 systematic review: 15 RCTs with 7053 individuals • 6% risk reduction (RR 0.94); not statistically significant • Overall study quality rated as low 4. Vitamin D reduces the frequency of respiratory tract infections • 2017 systematic review: 25 RCTs with 11,321 individuals • Overall odds ratio of 0.88 favoring Vit D • Not effective if given as bolus dosing q month or longer • Best effect for those with low Vit D (less than 25). OR 0.3

  5. Wheezing, asthma, COPD 5. Vitamin D supplementation during pregnancy does not prevent wheezing in the infant • RCT 623 Danish women: 2,400 IU vs 400 IU Vit D • 3 year follow up • No diff in wheezing, dx of asthma, eczema, URI 6. Prenatal vitamin D supplementation reduces risk of asthma/recurrent wheeze in early childhood • 1,387 women in 2 RCTs combined: 2400 IU or 4000 IU vs 400 • 26% risk reduction in asthma/wheezing by age 3 years • More effective if low vit D level • 6 year follow up shows no effect, however (JAMA 2019 Mar 12;321(10):1003-1005)

  6. Wheezing, asthma, COPD 7. Vitamin D reduces the risk of asthma exacerbations requiring systemic steroids • Meta-analysis 8 studies, 1078 patients • 26% risk reduction in steroid requiring exacerbations; best in those with low Vit D levels: 67% relative risk reduction • No difference in overall exacerbations, however 8. Vitamin D reduced COPD exacerbations in patients with low vitamin D levels • Meta-analysis of 4 studies, 560 patients • Reduced risk only in those with low Vit D levels (RR: =0.55)

  7. Pain 9. Vitamin D does not reduce pain in adults with symptomatic knee arthritis • RCT: 413 adults (340 completed study): 50,000 IU Vit D month for 2 years • Pain scores and cartilage volume same in both groups 10. Maintaining Vitamin D sufficiency Is associated with improved structural and symptomatic outcomes in knee osteoarthritis • Same study as 9 • Those with consistently higher vit D levels had somewhat better outcomes, suggesting Vit D MAY have some value • Biased analysis; needs confirmation

  8. Pain 11. Vitamin D for the treatment of chronic painful conditions in adults • 2015 Cochrane review: 10 studies with 810 participants • Inconsistent results; now quality; need better evidence 12. Vitamin D supplementation improves pain symptoms in patients with chronic widespread pain/fibromyalgia • 4 RCTs with 286 participants • Mean difference of 0.46 on a 10 point visual analog scale • But no correlation between Vit D levels and pain relief

  9. Fatigue and mental health 13. Vitamin D did not improve fatigue • 120 adults with fatigue and low Vit D but no diagnosed mental health condition; 50 point fatigue scale • RCT: Single large dose of Vit D: 100,000 IU or placebo • One month later, decrease 3.3 in Vit D group vs 0.8 in placebo • Statistically significant decline but not clinically meaningful diff. 14. Vitamin D does not improve symptoms of bipolar disorder • RCT: 5,000 IU Vit D vs. placebo for 12 weeks • Slightly better MADRS score (diff 3 points on 60 point scale) but no other differences

  10. Depression (not in syllabus) • MAYBE according to one meta-analysis: Vellekkatt F, Menon V. Efficacy of vitamin D supplementation in major depression: A meta-analysis of randomized controlled trials. J Postgrad Med. 2018, Jun 21. • NOT EFFECTIVE in recent randomized trial: Hansen JP, Pareek M, Hvolby A, Schmedes A, Toft T, Dahl E, Nielsen CT. Vitamin D3 supplementation and treatment outcomes in patients with depression. BMC Res Notes. 2019 Apr 3;12(1):203. 

  11. Cardiovascular disease and cancer 15. High dose bolus Vitamin D does NOT prevent cardiovascular disease • RCT: 5110 participants from New Zealand • 200,000 IU, then 100,000 IU Vit D/month for avg 3.3 years • CV events 11.8% vs 11.5% in placebo group • No benefit, even for those with low Vit D level 16. Vitamin D plus calcium does not reduce cancer risk in postmenopausal women • RCT: 2303; Vit D 2000 IU QD and calcium 500 mg tid • 4 year follow-up: 3.89% vs 5.58%, favoring intervention, but not statistically significant and underpowered

  12. Cardiovascular disease and cancer 17. No effect of Vitamin D on cancer mortality: meta-analysis • 2018 meta-analysis of 30 RCTs with 18,808 participants • No statistical diff in cancer rates or cancer deaths 18/19. Vitamin D supplements and prevention of cancer and cardiovascular disease • Large RCT of 25,871 participants • Vit D 2,000 IU and omega 3 fatty acid 1gm daily • Mean 5.3 year follow up: no statistically significant difference in any of many cancer and CV outcomes, including death

  13. Diabetes 20. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis • 2017 meta-analysis • 24 controlled trials (1528 individuals diagnosed with type 2 diabetes • Small positive effect on A1c: 0.3% lower • Clinical significance not measured

  14. What is a normal Vitamin D level? 21. Serum 25-Hydroxyvitamin D insufficiency in search of a bone disease • Cohort of 11,855 individuals in Australia • No biochemical abnormalities in bone metabolism (PTH, calcium, alkaline phosphotase) above a 25(OH) Vit D level of 12 ng/ml • Raises question about the current thresholds of 20 ng/ml for deficiency and 30 for insufficiency

  15. What is a normal Vitamin D level? “A common misconception is that the RDA functions as a “cut-point” and that nearly the entire population must have a serum 25(OH)D level above 20 ng per milliliter to achieve good bone health. The reality is that the majority (about 97.5%) of the population has a requirement of 20 ng per milliliter or less.” • Manson JE, Brannon PM, Rosen CJ, Taylor CL. Vitamin D Deficiency - Is There Really a Pandemic? N Engl J Med. 2016 Nov 10;375(19):1817-1820.

  16. Bottom Lines 1. Vitamin D modestly decreases frequency of acute respiratory infections. 2. Vitamin D decreases asthma exacerbations requiring steroids but not the rate of exacerbations. 3. Vitamin D reduces the frequency of moderate/severe COPD exacerbations in Vitamin D deficient individuals. 4. Vitamin D does not reduce pain from knee arthritis but does decrease the pain of chronic widespread pain syndrome.

  17. Bottom Lines 5. Vitamin D does not decrease fatigue in otherwise normal individuals and is not effective for bipolar disorder, and probably not depression, but the jury is out on depression. 6. Vitamin D decreases A1C in type 2 diabetes; the clinical significance is unknown. 7. Vitamin D does not decrease the incidence of cardiovascular disease or cancers. 8. Current laboratory ranges for normal vitamin D levels are probably inaccurately high

More Related